Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (DE:NOV)
XETRA:NOV
Holding DE:NOV?
Track your performance easily
NOV Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€87.19 - €138.48
Previous Close€100.2
Volume21.87K
Average Volume (3M)57.24K
Market Cap
€445.19B
Enterprise Value€444.76B
Total Cash (Recent Filing)kr30.23B
Total Debt (Recent Filing)kr27.01B
Price to Earnings (P/E)35.2
Beta0.18
Next Earnings
Feb 05, 2025EPS Estimate
€0.83Last Dividend Ex-Date
Aug 15, 2024Dividend Yield1.29%
Share Statistics
EPS (TTM)2.85
Shares Outstanding4,496,011,436
10 Day Avg. Volume110,347
30 Day Avg. Volume57,238
Standard Deviation0.08
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)2.82
Price to Sales (P/S)3.08
Price to Cash Flow (P/CF)3.60
P/FCF Ratio4.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€120.79Price Target Upside18.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Novo Nordisk News
Options Prices
Currently, No data available
---
Ownership Overview
5.27% Insiders
13.60% Mutual Funds
<0.01% Other Institutional Investors
73.61% Public Companies and
Individual Investors
NOV FAQ
What was Novo Nordisk’s price range in the past 12 months?
Novo Nordisk lowest stock price was €87.19 and its highest was €138.48 in the past 12 months.
What is Novo Nordisk’s market cap?
Currently, no data Available
When is Novo Nordisk’s upcoming earnings report date?
Novo Nordisk’s upcoming earnings report date is Feb 05, 2025 which is in 83 days.
How were Novo Nordisk’s earnings last quarter?
Novo Nordisk released its earnings results on Nov 06, 2024. The company reported €0.82 earnings per share for the quarter, beating the consensus estimate of €0.804 by €0.016.
Is Novo Nordisk overvalued?
According to Wall Street analysts Novo Nordisk’s price is currently Undervalued.
Does Novo Nordisk pay dividends?
Novo Nordisk pays a Annually dividend of €0.47 which represents an annual dividend yield of 1.29%. See more information on Novo Nordisk dividends here
What is Novo Nordisk’s EPS estimate?
Novo Nordisk’s EPS estimate is €0.83.
How many shares outstanding does Novo Nordisk have?
Novo Nordisk has 3,390,128,000 shares outstanding.
What happened to Novo Nordisk’s price movement after its last earnings report?
Novo Nordisk reported an EPS of €0.82 in its last earnings report, beating expectations of €0.804. Following the earnings report the stock price went up 0.671%.
Which hedge fund is a major shareholder of Novo Nordisk?
Currently, no hedge funds are holding shares in DE:NOV
---
Novo Nordisk Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€120.79 (18.84% Upside)
€120.79 (18.84% Upside)
Insider Transactions
Sold Shares
Worth kr4.7B over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.60%
12-Months-Change
Fundamentals
Return on Equity
88.73%
Trailing 12-Months
Asset Growth
32.44%
Trailing 12-Months
Company Description
Novo Nordisk
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
---
NOV Stock 12 Month Forecast
Average Price Target
€120.79
▲(18.84% Upside)
Technical Analysis
Best Analysts Covering NOV
1 Year
1 Year Success Rate
25/31 ratings generated profit
1 Year Average Return
+32.12%
reiterated a buy rating 7 days ago
Copying Emily Field's trades and holding each position for 1 Year would result in 80.65% of your transactions generating a profit, with an average return of +32.12% per trade.
---